American Portfolios Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

American Portfolios Advisors’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$41	Hold	16	–	–	﹤0.01%	3508
2022 Q2	$31	Hold	16	–	–	﹤0.01%	3514
2022 Q1	$48	Hold	16	–	–	﹤0.01%	3570
2021 Q4	$72	Hold	16	–	–	﹤0.01%	3489
2021 Q3	$78	Hold	16	–	–	﹤0.01%	3448
2021 Q2	$109	Hold	16	–	–	﹤0.01%	3372
2021 Q1	$113	Hold	16	–	–	﹤0.01%	3250
2020 Q4	$100	Hold	16	–	–	﹤0.01%	2954
2020 Q3	$87	Hold	16	–	–	﹤0.01%	2921
2020 Q2	$84	Hold	16	–	–	﹤0.01%	2823
2020 Q1	$50	Hold	16	–	–	﹤0.01%	2756
2019 Q4	$64	Buy	+16	New	+$56	﹤0.01%	2808

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

American Portfolios Advisors's PRTK Position: Q3 2022 in Review

American Portfolios Advisors held its Paratek Pharmaceuticals, Inc. (PRTK) position steady in Q3 2022 at 16 shares worth $41. The position accounts for ﹤0.01% of the portfolio, ranked #3508.

American Portfolios Advisors first reported a position in PRTK in Q4 2019 and has held it in 12 quarters since. The position peaked at $113 in Q1 2021. 72 funds tracked by Wall St. Rank hold PRTK as of Q3 2022.

American Portfolios Advisors held 16 shares of Paratek Pharmaceuticals, Inc. worth $41 as of Q3 2022.
American Portfolios Advisors left its Paratek Pharmaceuticals, Inc. share count unchanged in Q3 2022.
Paratek Pharmaceuticals, Inc. made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3508 holding.
American Portfolios Advisors first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2019 and has held it in 12 quarters since.
American Portfolios Advisors's Paratek Pharmaceuticals, Inc. position peaked at $113 in Q1 2021.
72 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.